BackGeneFerm Biotechnology , Ltd. Overview

GeneFerm Biotechnology , Ltd. Other Current Liabilities

GeneFerm Biotechnology , Ltd.'s other current liabilities is $91M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$90.83M
↑ 29.12% YoYΔ $20.49M vs prior year quarter

Peer trimmed avg / median

Loading

GeneFerm Biotechnology , Ltd. Other Current Liabilities History

Loading

GeneFerm Biotechnology , Ltd. vs. peers: Other Current Liabilities Comparison

Loading

GeneFerm Biotechnology , Ltd. Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GeneFerm Biotechnology , Ltd. (1796.TWO) FAQ

The latest other current liabilities for 1796.TWO is $91M as of September 2026. That compares with $70M in the prior-year period — up 29.1% year over year. Investors often review this figure alongside GeneFerm Biotechnology , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 1796.TWO's other current liabilities moved from $70M to $91M — a 29.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in GeneFerm Biotechnology , Ltd.'s operating scale or balance-sheet position.

A other current liabilities figure of $91M for 1796.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 1796.TWO's other current liabilities ($91M), review year-over-year change from $70M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.